Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)
Titel:
Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)
Auteur:
Vehreschild, Maria J. G. T. Taori, Surabhi Goldenberg, Simon D. Thalhammer, Florian Bouza, Emilio Oene, Joop van Wetherill, Graham Georgopali, Areti
Verschenen in:
European journal of clinical microbiology & infectious diseases